WO1999046265A1 - Method for preparing metal complex of porphyrin - Google Patents
Method for preparing metal complex of porphyrin Download PDFInfo
- Publication number
- WO1999046265A1 WO1999046265A1 PCT/JP1999/001113 JP9901113W WO9946265A1 WO 1999046265 A1 WO1999046265 A1 WO 1999046265A1 JP 9901113 W JP9901113 W JP 9901113W WO 9946265 A1 WO9946265 A1 WO 9946265A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- porphyrin
- metal complex
- group
- transition metal
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Definitions
- the invention of this application relates to a method for producing a porphyrin metal complex. More specifically, the invention of this application relates to a porphyrin in which a transition metal is inserted into a porphyrin ring, which is useful as a functional material such as a photoresponsive material and an organic electronic material. The present invention relates to a method for producing a phosphorous metal complex. Background art
- porphyrins found as substances involved in photosynthesis, studies on the control of their structures and chemical modification, and the use of photoresponsive materials as electronic materials have been advanced. ing.
- the invention of this application solves the above-mentioned problems of the conventional technology, and is simple and easy for any hydrophobic or hydrophilic porphyrin compound.
- a new method for producing a porphyrin metal complex that can insert a transition metal ion into a porphyrin ring with excellent selectivity by reaction at room temperature. The challenge is to provide Disclosure of the invention
- the present application provides, as a first invention, a method for producing a porphyrin metal complex in which a transition metal is inserted into a porphyrin ring. , Porphyrins and transition metal salts are separately dissolved in a solvent, and then the solutions of both are mixed and reacted in the presence of a base substance.
- a method for producing a porphyrin metal complex which is a feature of the present invention.
- this application relates to the first invention described above, as a second invention, a porphyrin metal complex in which a base substance is present as a solvent for dissolving the porphyrins.
- the production method is a third invention, and the production method of a porphyrin metal complex in which a base substance is added together with the solution to be present is referred to as a fourth invention.
- a method for producing a porphyrins metal complex which is reacted at a temperature of 0 ° C. or less is an inorganic salt of iron (Fe) or manganese (Mn).
- a method for producing a metal complex of porphyrins is a porphyrin which may or may not have a hydrophobic or hydrophilic substituent.
- the invention of this application has the features described above, but the essence is that, under mild conditions, it can be used as a homogeneous reaction, easily and with excellent selectivity, and Thus, it is possible to synthesize a metal complex of vorphyrins.
- a hydrophobic or hydrophilic porphyrin having a porphyrin ring and optionally having various substituents is the starting material.
- This starting material has a structure in which a transition metal ion can be inserted.
- the basic structure is, for example,
- R 1 to R ′ 2 in the formula represent a hydrogen atom or an organic group
- R 1 to R ′ 2 in the formula represent a hydrogen atom or an organic group
- Examples of the organic groups represented by R 1 to R 12 include, for example, linear groups such as an alkyl group, an alkenyl group, a cycloalkyl group, a phenyl group, and a naphthyl group. Or a cyclic saturated or unsaturated hydrocarbon group; a halogen atom, a hydroxy group, an alkoxy group, an alkoxycarbonyl group, which may be substituted with these hydrocarbon groups; Carboxyl group, amide group, amino group, nitro group, cyano group, sulfuric acid group, urea group, sulfonyl group, threphenyl group, phosphenyl group, phosphine group Various functional groups such as a phenyl group, a sulfide group, a thioether group and a thioester group; a pyridyl group, a piperidyl group, an azine group, an azole group, an imid
- R 1 to R 12 may also be bonded to each other via a heteroatom or a heteroatom to form a heterocyclic or carbocyclic ring through a heteroatom.
- the transition metal salt complexed to the porphyrins described above may be any of various transition metal salts having a valence of two or more.
- the transition metals include, for example, Fe, Ni, Co, Cu, Zn, Sn, Ti, Mn, Mo, V, Zr, Cd, Ga, and Sb. , Cr, Nb, AI and the like. Of these transition metals, in particular, in the present invention, Fe
- the salt of the transition metal may be any one of a salt of an inorganic acid, for example, hydrochloric acid, sulfuric acid, phosphoric acid and the like, or a salt of an organic acid. Is the among others suitable ones are F e CI 2, M n CI 2 of an inorganic acid salt.
- these transition metal salts are generally suitably used in a molar excess ratio to the starting porphyrins.
- the molar ratio is between 1.1 and 30 times, more preferably between 2 and 25 times, and more preferably between 5 and 20 times.
- the reaction is carried out by dissolving the porphyrins and the transition metal salt as starting materials, respectively, separately in a solvent, and then mixing the two solutions.
- Porphyrins and transitions The process of separately dissolving the metal salt and the solvent in a solvent and then mixing them is indispensable for the present invention.
- Solvents for dissolving porphyrins generally depend on whether the starting porphyrins themselves are hydrophobic or hydrophilic. You have the power to choose.
- the porphyrins are selected from those with high solubility and those that can be used as a homogeneous solution.
- a hydrophobic organic solvent is used for hydrophobic porphyrins. These include halogenated hydrocarbons, aromatic hydrocarbons, and nitriles.
- click throat Holm (CHCI) is exemplified by the Axis B B meth emissions (CH 2 CI 2) or the like halogenation one to have an organic solvent hydrocarbons preferred for.
- the porphyrins as a starting material are hydrophilic, they are generally hydrophilic solvents, for example, water, alcohols, amines, or nitrogen-containing heterocycles. And the like.
- the homogeneously dissolved solvent solution is then mixed, and at this time, the base material should be present in the mixed solution.
- the presence of the basic substance may be present in the reaction system by using it as a solvent, for example, as an amine or a nitrogen-containing heterocyclic compound solvent, By adding a basic substance to the mixture, the mixture may be used as a solvent, or may be present in the reaction system in combination with the addition. .
- the base substance for example, pyridin, methyl pyridin, dimethyl pyridine, diazine, methyl diazine, pyrazine, ethyl virazine, pyrimidine, piperazine Nitrogen-containing heterocyclic compounds such as gin and morpholine; aliphatic amines such as getylamine, ethylenediamine and tert-butylamine; or basic resins and inorganic bases. You can.
- organic base substances such as 2,6-lutidine are preferable.
- the temperature of the reaction can usually be below 40 ° C. Even if the temperature exceeds 40 ° C, this temperature will not be significantly exceeded. In practice, the reaction temperature can be at or near room temperature. In this respect, it is essentially different from the conventional method.
- the mixture was stirred at room temperature for 3 hours.
- the octaethylporphyrin Fe complex in which Fe was inserted into the porphyrin ring was obtained quantitatively (100% yield).
- Example 1 it had use the M n CI 2 in place of the F e CI 2.
- the reaction was performed at room temperature for 7 hours.
- an octaethylporphyrin Mn complex in which Mn was inserted into the porphyrin ring quantitatively was obtained.
- Example 3 have use the M n CI 2 in place of the F e CI 2, was reacted for 7 hours at room temperature.
- the hydrophilic coproporphyrin (16 mmoI) represented by the above formula (3) was dissolved in 2,6-lutidine (5 ml). On the other hand, it was dissolved F e CI 2 a (2 6 0 mo I) in METHANOL. Next, the obtained 2,6-lutidine solution and the FeCl 2 methanol solution were mixed, and the mixture was stirred at room temperature for 7 hours.
- a cup-shaped porphyrin Fe complex having Fe inserted in the porphyrin ring was obtained quantitatively.
- Example 5 it had use the M n CI 2 in place of the F e CI 2.
- the reaction was carried out by stirring at room temperature for 20 hours.
- Coprovozorefililine Mn complex in which Mn was inserted in the porphyrin ring was obtained quantitatively.
- hydrophilic mesoporphyrin 1X represented by the formula (1) was used instead of coproporphyrin.
- a mesoporphyrin 1 X Fe complex in which Fe was inserted into the vorphyrin ring was obtained quantitatively.
- Example 7 it was replaced with F e CI 2 to M n CI 2.
- the mixture was stirred for 20 hours to react.
- a mesoporphyrin 1XMn complex in which Mn was inserted into the porphyrin ring was obtained quantitatively.
- Hydrophobic tetraphenylporphyrin (16 ⁇ moI) represented by the above formula (5) was dissolved in clog mouth form (1 O ml). On the other hand, it was dissolved M n CI 2 a (2 6 0 mo I) in METHANOL Ichiru.
- Hydrophilic tetra (N-methylpyridyl) porphyrin (16 mOI) represented by the above formula (6) was dissolved in water (5 mI).
- MnCIz (260 / moI) was dissolved in methanol (3 mI).
- the mixture was stirred at room temperature for 24 hours.
- Tetra (N-methylpyridyl) porphyrin Mn complex in which Mn was inserted into the porphyrin ring was obtained quantitatively.
- the reaction was stirred at room temperature for about 1 hour.
- a heterodimer porphyrin zn-Mn complex was quantitatively obtained.
- the identification values of this were as follows.
- a porphyrin-based metal complex in which a transition metal is inserted into a porphyrin ring by an insert complex can be obtained by simple means, and Synthesized with high selectivity under mild conditions.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Catalysts (AREA)
Description
Claims
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE69936095T DE69936095T2 (de) | 1998-03-09 | 1999-03-08 | Verfahren zur herstellung eines porphyrin-metallkomplexes |
| EP99939144A EP1063237B1 (en) | 1998-03-09 | 1999-03-08 | Method for preparing metal complex of porphyrin |
| US09/646,448 US6420553B1 (en) | 1998-03-09 | 1999-03-08 | Method for preparing metal complex of porphyrin |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP05724698A JP3673888B2 (ja) | 1998-03-09 | 1998-03-09 | ポルフィリン類金属錯体の製造方法 |
| JP10/57246 | 1998-03-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1999046265A1 true WO1999046265A1 (en) | 1999-09-16 |
Family
ID=13050185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP1999/001113 Ceased WO1999046265A1 (en) | 1998-03-09 | 1999-03-08 | Method for preparing metal complex of porphyrin |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6420553B1 (ja) |
| EP (1) | EP1063237B1 (ja) |
| JP (1) | JP3673888B2 (ja) |
| AT (1) | ATE362476T1 (ja) |
| DE (1) | DE69936095T2 (ja) |
| WO (1) | WO1999046265A1 (ja) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7354771B2 (en) * | 1999-12-03 | 2008-04-08 | Japan Science And Technology Corporation | Method of determining absolute configuration of chiral compound |
| JP3416777B1 (ja) * | 2002-02-27 | 2003-06-16 | 科学技術振興事業団 | キラル化合物の絶対配置決定試薬および決定方法 |
| AU2003237349B2 (en) | 2002-06-04 | 2010-06-03 | Infacare Pharmaceutical Corporation | Preparation of metal mesoporphyrin halide compounds |
| US7375216B2 (en) * | 2002-06-04 | 2008-05-20 | Infacare Pharmaceutical Corporation | Preparation of metal mesoporphyrin compounds |
| GB2397067B (en) * | 2002-12-23 | 2005-05-11 | Destiny Pharma Ltd | Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation |
| EP2330132B1 (en) | 2003-04-04 | 2013-08-14 | Yeda Research and Development Co. Ltd. | Antibodies against MMP2 or MMP9 and pharmaceutical compositions containing same useful for inhibiting activity of said metalloproteins |
| GB2415372A (en) | 2004-06-23 | 2005-12-28 | Destiny Pharma Ltd | Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent |
| WO2006075678A1 (ja) * | 2005-01-14 | 2006-07-20 | Hamamatsu Foundation For Science And Technology Promotion | 光感受性化合物 |
| US20060222668A1 (en) * | 2005-04-01 | 2006-10-05 | Wellspring Pharmaceutical Corporation | Stannsoporfin compositions, drug products and methods of manufacture |
| JP4708973B2 (ja) * | 2005-05-31 | 2011-06-22 | 富士シリシア化学株式会社 | 水検出用組成物、および水検出用インジケーター |
| EP1764235A1 (en) | 2005-09-08 | 2007-03-21 | The Goodyear Tire & Rubber Company | Pneumatic tire containing a zinc compound |
| US7968630B2 (en) * | 2005-09-08 | 2011-06-28 | The Goodyear Tire & Rubber Company | Pneumatic tire containing zinc porphyrin compound |
| CN101573122B (zh) * | 2006-10-04 | 2016-08-03 | 婴儿护理药品公司 | 锡泊芬的高纯度大规模制备 |
| WO2008045378A2 (en) * | 2006-10-04 | 2008-04-17 | Infacare Pharmaceutical Corporation | Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin |
| CN101878310B (zh) * | 2007-11-30 | 2017-08-08 | 福留裕文 | 四吡咯化合物的制备方法及四吡咯化合物 |
| US8735574B2 (en) | 2011-03-30 | 2014-05-27 | Infacare Pharmaceutical Corporation | Methods for synthesizing metal mesoporphyrins |
| US9406934B2 (en) * | 2012-02-07 | 2016-08-02 | Basf Corporation | Rechargeable battery cell with improved high temperature performance |
| KR101894575B1 (ko) | 2017-01-03 | 2018-09-04 | 주식회사 인트론바이오테크놀로지 | 돼지 피로부터 유래되지 않은 헴철을 제조할 수 있는 화학적 방법 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59164790A (ja) * | 1983-03-09 | 1984-09-17 | Hidetoshi Tsuchida | 5,10,15−トリ〔α,α,α−(o−ピバラミド)フエニル〕−20−モノ{α−〔o−(2−置換−2−メチル)プロパンアミド〕フエニル}ポルフイリン化合物および酸素吸脱着剤 |
| JPH02259750A (ja) * | 1989-03-31 | 1990-10-22 | Toray Ind Inc | ポリフィリン系記録材料 |
| JPH04283580A (ja) * | 1991-03-13 | 1992-10-08 | Asahi Chem Ind Co Ltd | 含フッ素ポルフィリン |
| JPH06184156A (ja) * | 1992-03-17 | 1994-07-05 | Res Inst For Prod Dev | 近位塩基を持つポルフィリン金属錯体 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1321013A (fr) * | 1962-03-13 | 1963-03-15 | Blood Plasma Corp Of Japan | Procédé de préparation d'une cobaltiprotoporphyrine |
| FR2566776B1 (fr) * | 1984-06-27 | 1986-12-26 | Univ Picardie | Procede de preparation de metalloporphyrines |
| US5192757A (en) * | 1990-12-20 | 1993-03-09 | Glaxo Inc. | Cobalt porphyrins |
-
1998
- 1998-03-09 JP JP05724698A patent/JP3673888B2/ja not_active Expired - Fee Related
-
1999
- 1999-03-08 EP EP99939144A patent/EP1063237B1/en not_active Expired - Lifetime
- 1999-03-08 DE DE69936095T patent/DE69936095T2/de not_active Expired - Lifetime
- 1999-03-08 AT AT99939144T patent/ATE362476T1/de not_active IP Right Cessation
- 1999-03-08 WO PCT/JP1999/001113 patent/WO1999046265A1/ja not_active Ceased
- 1999-03-08 US US09/646,448 patent/US6420553B1/en not_active Expired - Lifetime
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59164790A (ja) * | 1983-03-09 | 1984-09-17 | Hidetoshi Tsuchida | 5,10,15−トリ〔α,α,α−(o−ピバラミド)フエニル〕−20−モノ{α−〔o−(2−置換−2−メチル)プロパンアミド〕フエニル}ポルフイリン化合物および酸素吸脱着剤 |
| JPH02259750A (ja) * | 1989-03-31 | 1990-10-22 | Toray Ind Inc | ポリフィリン系記録材料 |
| JPH04283580A (ja) * | 1991-03-13 | 1992-10-08 | Asahi Chem Ind Co Ltd | 含フッ素ポルフィリン |
| JPH06184156A (ja) * | 1992-03-17 | 1994-07-05 | Res Inst For Prod Dev | 近位塩基を持つポルフィリン金属錯体 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11255790A (ja) | 1999-09-21 |
| JP3673888B2 (ja) | 2005-07-20 |
| ATE362476T1 (de) | 2007-06-15 |
| EP1063237A1 (en) | 2000-12-27 |
| DE69936095D1 (de) | 2007-06-28 |
| EP1063237B1 (en) | 2007-05-16 |
| DE69936095T2 (de) | 2008-01-10 |
| US6420553B1 (en) | 2002-07-16 |
| EP1063237A4 (en) | 2004-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1999046265A1 (en) | Method for preparing metal complex of porphyrin | |
| Singh et al. | Ferrocene-appended pharmacophores: An exciting approach for modulating the biological potential of organic scaffolds | |
| TWI289565B (en) | Process for preparing amine platinum complexes | |
| Yarkandi et al. | Synthesis, spectroscopic and DNA binding ability of CoII, NiII, CuII and ZnII complexes of Schiff base ligand (E)-1-(((1H-benzo [d] imidazol-2-yl) methylimino) methyl) naphthalen-2-ol. X-ray crystal structure determination of cobalt (II) complex | |
| Preston et al. | Heterometallic [M n Pt n (L) 2 n] x+ Macrocycles from Dichloromethane-Derived Bis-2-pyridyl-1, 2, 3-triazole Ligands | |
| Kumar et al. | Structure, DNA/proteins binding, docking and cytotoxicity studies of copper (II) complexes with the first quinolone drug nalidixic acid and 2, 2′‑dipyridylamine | |
| Manikandan et al. | Synthesis, structure and in vitro biological activity of pyridoxal N (4)-substituted thiosemicarbazone cobalt (III) complexes | |
| Panja et al. | Solvent-triggered cis/trans isomerism in cobalt dioxolene chemistry: Distinguishing effects of packing on valence tautomerism | |
| CN112592339B (zh) | 1,3,4-恶二唑-2(3h)-硫酮-诺氟沙星杂合体及其制备方法和应用 | |
| Brown et al. | Syntheses, structures, and spectral properties of a synthetic analog of copper (II)-bleomycin and an intermediate in the process of its formation | |
| Bharty et al. | Studies on novel Cu (II) complexes of 5-(4-hydroxy-phenyl)-1, 3, 4-thiadiazole-2-thiol and 5-thiophen-2-yl-3H-1, 3, 4-oxadiazole-2-thione: Synthesis, spectral and structural characterization | |
| Maheshwari et al. | Chemistry of HIV-1 virucidal pt complexes having neglected bidentate sp2 N-donor carrier ligands with linked triazine and pyridine rings. synthesis, NMR spectral features, structure, and reaction with guanosine | |
| Ostrowska et al. | Explaining how α-hydroxamate ligands control the formation of Cu (II)-, Ni (II)-, and Zn (II)-containing metallacrowns | |
| Fursova et al. | Copper (II) complexes with imidazol-4-yl derivatives of 2-imidazoline nitroxides | |
| Zaworotko et al. | Ampicillin acidity and formation constants with some metals and their thermodynamic parameters in different media. Crystal structures of two polymorphs isolated from the reaction of ampicillin with copper (II) | |
| Qian et al. | Synthesis of dinuclear metal complexes of a macrocyclic ligand with multi-ligating pendant-arms. Crystal structures of its manganese (II) and cadmium (II) complexes | |
| Benaissa et al. | Exploring “Triazole-Thiourea” Based Ligands for the Self-Assembly of Photoluminescent Hg (II) Coordination Compounds | |
| Morita et al. | Novel building blocks for crystal engineering: the first synthesis of oligo (imidazole) s | |
| Ito et al. | Versatility of pyridine-2-methanol as a chelating ligand toward a manganese ion: synthesis and X-ray structural analysis on some manganese-pyridine-2-methanol derivatives | |
| Zhu et al. | Access to 2-pyridinones comprising enaminonitriles via AgOAc promoted cascade reactions of thioesters with aminomethylene malononitriles | |
| Back et al. | Synthesis and structural features of UVI and VIV chelate complexes with (hhmmbH) Cl· H2O [hhmmb={3-hydroxyl-5-(hydroxymethyl)-2-methylpyridine-4-yl-methylene} benzohydrazide], a new Schiff base ligand derived from vitamin B6 | |
| CN106622375B (zh) | 一种2,4-二羟基苯甲醛缩氨基酸镍催化剂、制备方法及应用 | |
| Anacona et al. | Synthesis and characterization of transition metal complexes with a Schiff base derived from cephalexin and 1, 2–diaminobenzene. antibacterial activity | |
| Soong et al. | Chemical and electrochemical redox transformations of oxomolybdenum and oxotungsten tetrathiolate complexes | |
| Kudayarova et al. | Synthesis and structure of 3, 5-diamino-1, 2, 4-triazolium tetrachloro-gallate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 1999939144 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 09646448 Country of ref document: US |
|
| WWP | Wipo information: published in national office |
Ref document number: 1999939144 Country of ref document: EP |
|
| WWG | Wipo information: grant in national office |
Ref document number: 1999939144 Country of ref document: EP |